HIF-1α Inhibits Wnt Signaling Pathway by Activating Sost Expression in Osteoblasts
Open Access
- 11 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6), e65940
- https://doi.org/10.1371/journal.pone.0065940
Abstract
The nature of the cellular and molecular mechanisms for the transition of avascular cartilage replacement with bone during endochondral ossification remains poorly understood. One of the driving forces is hypoxia. As a master regulator of hypoxia, hypoxia-inducible factor-1α (HIF-1α) has been reported to couple angiogenesis to osteogenesis. Our recent study has demonstrated that osteoblast growth is inhibited under hypoxia and that HIF-1α cooperates with Osterix (Osx) to inhibit Wnt pathway. However, molecular mechanisms for inhibitory effects of HIF-1α on Wnt pathway are not well understood. In this study, our quantitative RT-PCR results revealed that the expression of a Wnt antagonist Sclerostin (Sost) was upregulated in osteoblasts during hypoxia while HIF-1α was upregulated. Treatment of desferrioxamine (DFO), a HIF-1α activator, led to further increase of Sost expression, suggesting that HIF-1α may activate Sost expression. The regulation of Sost gene expression by HIF-1α was then investigated. We performed loss-of-function experiments to examine Sost expression by using siRNA approach against HIF-1α, and found that the inhibition of HIF-1α by siRNA in osteoblasts led to the decrease of Sost expression. To address transcriptional regulation of Sost gene by HIF-1α, transient transfection assay was performed and showed that HIF-1α activated Sost-1 kb promoter reporter activity in a dose-dependent manner. To narrow down the minimal region of Sost promoter activated by HIF-1α, we generated a series of deletion mutants of Sost constructs. It was demonstrated that Sost-260 was the minimal region of Sost promoter for HIF-1α activation and that Sost-106 construct, which lack hypoxia response element, abolished HIF-1α-mediated Sost reporter activation. Gel shift assay showed that HIF-1 bound to the promoter sequence of Sost directly. These findings support our hypothesis that HIF-1α activates Sost expression. This study provides a novel molecular mechanism through which HIF-1α inhibits Wnt signaling in osteoblastsKeywords
This publication has 35 references indexed in Scilit:
- Molecular mechanisms of osteoblast-specific transcription factor Osterix effect on bone formation.2012
- Osteoblast-specific Transcription Factor Osterix (Osx) Is an Upstream Regulator of Satb2 during Bone FormationPublished by Elsevier BV ,2011
- Role of HIF‐1α in skeletal developmentAnnals of the New York Academy of Sciences, 2010
- Inhibition of Wnt signaling by the osteoblast-specific transcription factor OsterixProceedings of the National Academy of Sciences of the United States of America, 2008
- Role of Wnt Signaling in Bone Remodeling and RepairHSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2008
- Distinct roles for Hedgehog and canonical Wnt signaling in specification,differentiation and maintenance of osteoblast progenitorsDevelopment, 2006
- Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone MassJournal of Bone and Mineral Research, 2006
- Regulation of bone mass by Wnt signalingJCI Insight, 2006
- Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptorThe Journal of cell biology, 2002
- LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye DevelopmentCell, 2001